The Scientific Advisory Board are Internationally respected scientists in the area of the company's technology development.
Executive Director, Founder, Center for Translational Imaging, Georgetown Medical Center. At the Lombardi Comprehensive Cancer Center, Dr. Albanese conducts development of novel preclinical models of human diseases, and the development of high-energy imaging technologies. Dr. Albanese heads a multidisciplinary group of investigators whose initiative is to develop novel imaging-based clinical cancer therapies. Dr. Albanese completed his M.S., in Molecular Biology and B.A., Biology at State University of New York. He worked for Nobel Laureate Dr. David Baltimore at Massachusetts Institute of Technology (MIT), then completed his Ph.D., (Biology Cardiff University) prior to assuming faculty positions at Albert Einstein College of Medicine in New York and then Georgetown University, DC where he is currently a tenured Professor. https://gumc.georgetown.edu/gumc-stories/center-for-translational-imaging-to-capitalize-on-georgetowns-history-and-expertise-in-imaging-science/ Center for Translational Imaging (CTI), combines the revealing forces of the Preclinical Imaging Research Laboratory (PIRL) and the Center for Functional and Molecular Imaging (CFMI).
https://gufaculty360.georgetown.edu/s/contact/00336000014RaD9AAK/christopher-albanese
https://lombardi.georgetown.edu/research/sharedresources/amsr/preclinical-imaging-lab/staff/
Scientific Director, Division of Perinatal Research Kolling Institute of Medical Research. Professor Ashton is internationally known for his cardiovascular research including mechanisms of cardiac death and mechanisms governing cardiac progenitor cell function. He received his PhD from the University of New South Wales and spent 12 years in cardiovascular research at the Albert Einstein College of Medicine in New York prior to his current position at the Kolling Institute in Sydney Australia.
https://www.linkedin.com/in/anthony-ashton-524a9a33/?originalSubdomain=au
Professor Martin Schnermann PhD
Senior Investigator, Head Organic Synthesis, National Cancer Institute.
Dr. Schnermann attended Colby College and graduated in 2002 with degrees in Chemistry and Physics. At Colby, he worked with Prof. Dasan Thamattoor in the areas of physical organic chemistry and photochemistry. After a year at Pfizer Research and Development (Groton, CT) as an associate in the medicinal chemistry division, he moved to the Scripps Research Institute. During his graduate studies, he performed research on the total synthesis and biological evaluation of anticancer natural products with Prof. Dale Boger and obtained a Ph.D. in 2008. He then completed an NIH-postdoctoral fellowship with Prof. Larry Overman at the University of California, Irvine. At Irvine, he developed light-mediated reactions to enable the synthesis of complex natural products. In addition, working with Prof. Christine Suetterlin, he pursued chemical biology and imaging studies of organelle specific probes. In 2012, Dr. Schnermann joined the NCI where his research focuses on the synthesis and development of new small-molecule imaging agents for cancer treatment and diagnosis. He was awarded tenure in 2018.His areas of expertise include: 1). complex molecule synthesis, 2). synthetic methodology, 3). near-IR fluorescence, 4). natural product chemistry, 5). drug discovery, 6). drug delivery. https://ccr.cancer.gov/Chemical-Biology-Laboratory/martin-j-schnermann
Professor of Radiology and Director of Medical Physics, Georgetown University. Professor Fricke is an international thought leader in imaging technologies. He completed his M.S. from Massachusetts Institute of Technology, his B.S., in Physics from North Park University and his D. Phil from Università degli Studi di Torino. https://www.linkedin.com/in/stan-fricke-10ba947/
https://scholar.google.com/citations?user=BIvwu5wAAAAJ&hl=en
Copyright © 2023 LightSeed LLC - All Rights Reserved.
Powered by GoDaddy Website Builder